ConductScience.org, home

Paper72108

Immunologic properties of purified Sendai virus glycoproteins.

Orvell C and 1 other. J Immunol, 1977. Cited by 38 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Immunologic properties of purified Sendai virus glycoproteins. Papers, record 72108. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/72108

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunologic properties of purified Sendai virus glycoproteins.
PubMed
Journal
J Immunol
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
1.34
iCite
Revised in PubMed
2005-11-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Orvell CC
2Norrby EE

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlycoproteinsMajor topic
Parainfluenza Virus 1, HumanMajor topic
Animals
Binding, Competitive
Chromatography, Gel
Immune Sera
Immunodiffusion
Isoelectric Focusing
Rabbits
gamma-Globulins

Source PubMed

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
6,766,174Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection.J Exp Med1980https://conductscience.org/library/papers/6766174PubMed
6,743,025Biological functions of monospecific antibodies to envelope glycoproteins of Newcastle disease virus.Arch Virol1984https://conductscience.org/library/papers/6743025PubMed
6,254,880Separation of Sendai virus glycoproteins by using glutaraldehyde-treated erythrocytes and preparation of monospecific antisera against the glycoproteins.Infect Immun1980https://conductscience.org/library/papers/6254880PubMed
4,069,997Respiratory syncytial virus envelope glycoprotein (G) has a novel structure.Nucleic Acids Res1985https://conductscience.org/library/papers/4069997PubMed
3,755,730Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine.J Clin Microbiol1986https://conductscience.org/library/papers/3755730PubMed
3,573,154Comparison of the relative roles of the F and HN surface glycoproteins of the paramyxovirus simian virus 5 in inducing protective immunity.J Virol1987https://conductscience.org/library/papers/3573154PubMed
3,037,121Immunoglobulin A monoclonal antibodies protect against Sendai virus.J Virol1987https://conductscience.org/library/papers/3037121PubMed
2,994,598The effects of monoclonal antibodies against the hemagglutinin-neuraminidase and fusion protein on the release of Sendai virus from infected cells.Arch Virol1985https://conductscience.org/library/papers/2994598PubMed
2,987,829Respiratory syncytial virus fusion glycoprotein: nucleotide sequence of mRNA, identification of cleavage activation site and amino acid sequence of N-terminus of F1 subunit.Nucleic Acids Res1985https://conductscience.org/library/papers/2987829PubMed
2,437,318
Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities.
J Virol1987https://conductscience.org/library/papers/2437318PubMed
1,690,533Correlation between the reactivity patterns of monoclonal antibodies to distinct antigenic sites on HN glycoprotein and their protective abilities in Sendai (6/94) virus infection.Arch Virol1990https://conductscience.org/library/papers/1690533PubMed
528,055Use of antibodies to purified Newcastle disease virus glycoproteins for strain comparisons and characterizations.Infect Immun1979https://conductscience.org/library/papers/528055PubMed
229,798Role of envelope proteins of paramyxoviruses in the modification of cell membrane antigens.Arch Virol1979https://conductscience.org/library/papers/229798PubMed
227,914Immunofluorescence and electron microscopy of the cytoplasmic surface of the human erythrocyte membrane and its interaction with Sendai virus.J Cell Biol1979https://conductscience.org/library/papers/227914PubMed
214,512The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins.J Exp Med1978https://conductscience.org/library/papers/214512PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/72108

GET https://conductscience.org/api/papers/v1/72108/authors